Search Results

Filter
  • 1-10 of  62,093 results for ""RITUXIMAB""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data.

  • Authors : Roberto G; Agenzia Regionale di Sanità della Toscana, Firenze, Italy.; Spini A

Subjects: Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*administration & dosage ; Drug Utilization/Drug Utilization/Drug Utilization/*statistics & numerical data ; Infections/Infections/Infections/*epidemiology

  • Source: PloS one [PLoS One] 2020 Mar 12; Vol. 15 (3), pp. e0229973. Date of Electronic Publication: 2020 Mar 12 (Print Publication: 2020).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Yttrium-90 ibritumomab tiuxetan consolidation versus rituximab maintenance therapy after induction chemotherapy in patients with indolent non-Hodgkin lymphoma: a single-institution experience.

  • Authors : Iino M; Department of Hematology and Hematopoietic Stem Cell Transplantation, Yamanashi Prefectural Central Hospital , Kofu, Yamanashi , Japan.; Sakamoto Y

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Induction Chemotherapy/Induction Chemotherapy/Induction Chemotherapy/*methods

  • Source: Hematology (Amsterdam, Netherlands) [Hematology] 2019 Dec; Vol. 24 (1), pp. 623-630.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print Cited Medium: Internet ISSN: 1607-8454

Record details

×
Academic Journal

Cost effectiveness of rituximab and mycophenolate mofetil for neuromyelitis optica spectrum disorder in Thailand: Economic evaluation and budget impact analysis.

  • Authors : Aungsumart S; Neuroimmunology Unit, Department of Neurology, Prasat Neurological Institute, Bangkok, Thailand.; Apiwattanakul M

Subjects: Cost-Benefit Analysis* ; Drug Costs*; Mycophenolic Acid/Mycophenolic Acid/Mycophenolic Acid/*economics

  • Source: PloS one [PLoS One] 2020 Feb 12; Vol. 15 (2), pp. e0229028. Date of Electronic Publication: 2020 Feb 12 (Print Publication: 2020).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphoma.

  • Authors : Kayamori K; a Department of Hematology , Chiba Aoba Municipal Hospital , Chiba , Japan.; b Department of Hematology , Chiba University Hospital , Chiba , Japan.

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage ; Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/*drug therapy ; Rituximab/Rituximab/Rituximab/*administration & dosage

  • Source: Hematology (Amsterdam, Netherlands) [Hematology] 2019 Dec; Vol. 24 (1), pp. 52-59. Date of Electronic Publication: 2018 Aug 11.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Rituximab treatment for lupus nephritis: A systematic review.

Subjects: LUPUS nephritis; RITUXIMAB; META-analysis

  • Source: Clinical & Investigative Medicine. Jun2020, Vol. 43 Issue 2, pE47-E54. 8p.

Record details

×
Academic Journal

Effectiveness and safety analysis of rituximab in 146 Indian pemphigus patients: A retrospective single-center review of up to 68 months follow-up.

  • Authors : De D; Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.; Bishnoi A

Subjects: Immunologic Factors/Immunologic Factors/Immunologic Factors/*therapeutic use ; Pemphigus/Pemphigus/Pemphigus/*drug therapy ; Rituximab/Rituximab/Rituximab/*therapeutic use

  • Source: Indian journal of dermatology, venereology and leprology [Indian J Dermatol Venereol Leprol] 2020 Jan-Feb; Vol. 86 (1), pp. 39-44.Publisher: Medknow Publications Country of Publication: India NLM ID: 7701852 Publication Model: Print Cited Medium: Internet ISSN: 0973-3922

Record details

×
Academic Journal

Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis.

  • Authors : Huoponen S; University of Helsinki, Helsinki, Finland.; ESiOR Oy, Kuopio, Finland.

Subjects: Abatacept*/Abatacept*/Abatacept*/economics ; Abatacept*/Abatacept*/Abatacept*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/economics

  • Source: PloS one [PLoS One] 2019 Jul 24; Vol. 14 (7), pp. e0220142. Date of Electronic Publication: 2019 Jul 24 (Print Publication: 2019).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial.

  • Authors : Montillo M; Department of Hematology, Niguarda Cancer Center, Niguarda Hospital, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy. .; Illés Á

Subjects: Quality of Life*; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage ; Bendamustine Hydrochloride/Bendamustine Hydrochloride/Bendamustine Hydrochloride/*administration & dosage

  • Source: Health and quality of life outcomes [Health Qual Life Outcomes] 2019 Nov 15; Vol. 17 (1), pp. 173. Date of Electronic Publication: 2019 Nov 15.Publisher: BioMed Central Country of Publication: England NLM ID: 101153626 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7525

Record details

×
Academic Journal

Single fixed low-dose rituximab as induction therapy suppresses de novo donor-specific anti-HLA antibody production in ABO compatible living kidney transplant recipients.

  • Authors : Tomita Y; Department of Surgery, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.; Iwadoh K

Subjects: ABO Blood-Group System/ABO Blood-Group System/ABO Blood-Group System/*immunology ; Graft Rejection/Graft Rejection/Graft Rejection/*drug therapy ; Graft Survival/Graft Survival/Graft Survival/*drug effects

  • Source: PloS one [PLoS One] 2019 Oct 23; Vol. 14 (10), pp. e0224203. Date of Electronic Publication: 2019 Oct 23 (Print Publication: 2019).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Comparative research on 99m Tc-Rituximab and 99m Tc-sulfur colloid in sentinel lymph node imaging of breast cancer.

  • Authors : Zhang JJ; Department of nuclear medicine, Hebei General Hospital, Shijiazhuang, China.; Zhang WC

Subjects: Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*pathology ; Colloids/Colloids/Colloids/*chemistry ; Organotechnetium Compounds/Organotechnetium Compounds/Organotechnetium Compounds/*administration & dosage

  • Source: BMC cancer [BMC Cancer] 2019 Oct 15; Vol. 19 (1), pp. 956. Date of Electronic Publication: 2019 Oct 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
  • 1-10 of  62,093 results for ""RITUXIMAB""